8-K Announcements
6Feb 19, 2026·SEC
Jan 20, 2026·SEC
Oct 30, 2025·SEC
Medical Properties Trust, Inc. (MPW) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Medical Properties Trust, Inc. (MPW) stock price & volume — 10-year historical chart
Medical Properties Trust, Inc. (MPW) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Medical Properties Trust, Inc. (MPW) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 26, 2026 | $0.18vs $0.15+20.0% | $270M |
| Q4 2025 | Oct 30, 2025 | $0.13vs $0.16-18.8% | $238Mvs $244M-2.7% |
| Q3 2025 | Jul 31, 2025 | $0.14vs $0.15-6.7% | $240Mvs $245M-1.8% |
| Q2 2025 | May 1, 2025 | $0.14vs $0.15-6.7% | $224Mvs $240M-6.8% |
Medical Properties Trust, Inc. (MPW) competitors in Hospitals and inpatient facilities — business model, growth, and fundamentals comparison
Medical Properties Trust, Inc. (MPW) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Medical Properties Trust, Inc. (MPW) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 704.75M | 784.52M | 870.25M | 1.25B | 1.54B | 1.54B | 871.8M | 995.55M | 972.02M |
| Revenue Growth % | 30.23% | 11.32% | 10.93% | 43.55% | 23.65% | -0.12% | -43.49% | 14.19% | -2.36% |
| Property Operating Expenses | 5.81M | 9.24M | 23.99M | 24.89M | 39.1M | 45.7M | 41.57M | 27.25M | 0 |
| Net Operating Income (NOI) | 698.93M▲ 0% | 775.28M▲ 10.9% | 846.26M▲ 9.2% | 1.22B▲ 44.7% | 1.51B▲ 23.0% | 1.5B▼ 0.6% | 830.23M▼ 44.5% | 968.29M▲ 16.6% | 972.02M▲ 0.4% |
| NOI Margin % | 99.18% | 98.82% | 97.24% | 98.01% | 97.47% | 97.04% | 95.23% | 97.26% | 100% |
| Operating Expenses | 213.35M | 775.28M | 96.41M | 1.22B | 466.89M | 493.47M | 748.95M | 581.45M | 972.02M |
| G&A Expenses | 58.6M | 81M | 96.41M | 131.66M | 145.64M | 160.49M | 145.59M | 133.79M | 130.43M |
| EBITDA | 617.56M | 702.69M | 906.42M | 1.1B | 1.37B | 1.35B | 697.41M | 840.6M | 28.09M |
| EBITDA Margin % | 87.63% | 89.57% | 104.16% | 88.41% | 88.85% | 87.45% | 80% | 84.44% | 2.89% |
| Depreciation & Amortization | 131.98M | 141.49M | 156.57M | 275.95M | 333.78M | 345.58M | 616.13M | 453.75M | 265.4M |
| D&A / Revenue % | 18.73% | 18.04% | 17.99% | 22.09% | 21.61% | 22.4% | 70.67% | 45.58% | 27.3% |
| Operating Income | 485.58M▲ 0% | 561.2M▲ 15.6% | 749.85M▲ 33.6% | 0▼ 100.0% | 1.04B▲ 0% | 1B▼ 3.4% | 81.28M▼ 91.9% | 386.85M▲ 375.9% | 0▼ 100.0% |
| Operating Margin % | 68.9% | 71.53% | 86.16% | 0% | 67.24% | 65.05% | 9.32% | 38.86% | 0% |
| Interest Expense | 176.95M | 223.27M | 237.83M | 356.91M | 395.04M | 368.49M | 410.89M | 422.12M | 0 |
| Interest Coverage | 2.74x | 2.51x | 3.15x | - | 2.63x | 2.72x | 0.20x | 0.92x | - |
| Non-Operating Income | -29.64M | 0 | 152.31M | -828.44M | 0 | 0 | 0 | 0 | 237.32M |
| Pretax Income | 293.92M▲ 0% | 1.02B▲ 246.8% | 373.78M▼ 63.3% | 463.33M▲ 24.0% | 730.89M▲ 57.7% | 959.72M▲ 31.3% | -686.77M▼ 171.6% | -2.36B▼ 244.2% | -237.32M▲ 90.0% |
| Pretax Margin % | 41.71% | 129.94% | 42.95% | 37.09% | 47.32% | 62.2% | -78.78% | -237.48% | -24.41% |
| Income Tax | 2.68M | 927K | -2.62M | 31.06M | 73.95M | 55.9M | -130.68M | 44.1M | -38.62M |
| Effective Tax Rate % | 0.91% | 0.09% | -0.7% | 6.7% | 10.12% | 5.82% | 19.03% | -1.87% | 16.27% |
| Net Income | 289.79M▲ 0% | 1.02B▲ 250.8% | 374.68M▼ 63.1% | 431.45M▲ 15.2% | 656.02M▲ 52.1% | 902.6M▲ 37.6% | -556.48M▼ 161.7% | -2.41B▼ 333.1% | -198.7M▲ 91.8% |
| Net Margin % | 41.12% | 129.59% | 43.05% | 34.54% | 42.47% | 58.5% | -63.83% | -242.11% | -20.44% |
| Net Income Growth % | 28.77% | 250.83% | -63.15% | 15.15% | 52.05% | 37.59% | -161.65% | -333.13% | 91.76% |
| Funds From Operations (FFO) | 421.77M▲ 0% | 1.16B▲ 174.6% | 531.26M▼ 54.1% | 707.4M▲ 33.2% | 989.8M▲ 39.9% | 1.25B▲ 26.1% | 59.65M▼ 95.2% | -1.96B▼ 3379.9% | 66.7M▲ 103.4% |
| FFO Margin % | 59.85% | 147.63% | 61.05% | 56.63% | 64.08% | 80.9% | 6.84% | -196.53% | 6.86% |
| FFO Growth % | 30.72% | 174.6% | -54.13% | 33.16% | 39.92% | 26.1% | -95.22% | -3379.95% | 103.41% |
| FFO per Share | 1.20 | 3.16 | 1.24 | 1.33 | 1.68 | 2.08 | 0.10 | -3.26 | 0.11 |
| FFO Payout Ratio % | 77.47% | 31.42% | 77.49% | 80.29% | 65.01% | 55.96% | 1031.65% | -16.41% | 0% |
| EPS (Diluted) | 0.82▲ 0% | 2.76▲ 236.6% | 0.87▼ 68.5% | 0.81▼ 6.9% | 1.11▲ 37.0% | 1.50▲ 35.1% | -0.93▼ 162.0% | -4.02▼ 332.3% | -0.33▲ 91.8% |
| EPS Growth % | -4.65% | 236.59% | -68.48% | -6.9% | 37.04% | 35.14% | -162% | -332.26% | 91.79% |
| EPS (Basic) | 0.82 | 2.77 | 0.87 | 0.81 | 1.11 | 1.50 | -0.93 | -4.02 | -0.33 |
| Diluted Shares Outstanding | 350.44M | 366.27M | 428.3M | 530.46M | 590.14M | 598.84M | 598.52M | 600.32M | 600.89M |
Medical Properties Trust, Inc. (MPW) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 9.02B | 8.84B | 14.47B | 16.83B | 20.52B | 19.66B | 18.3B | 14.29B | 15B |
| Asset Growth % | 40.53% | -1.96% | 63.59% | 16.32% | 21.93% | -4.2% | -6.88% | -21.91% | 4.95% |
| Real Estate & Other Assets | -6.12B | -6.44B | 1.48B | 416.2M | 450.43M | 14.99B | 13.65B | 11.38B | 0 |
| PP&E (Net) | 4.95B | 4.45B | 6.99B | 10.06B | 11.8B | 0 | 0 | 0 | 0 |
| Investment Securities | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 |
| Total Current Assets | 436.03M | 1.07B | 4.51B | 4.04B | 4.55B | 1.72B | 1.4B | 1.31B | 1.44B |
| Cash & Equivalents | 171.47M | 820.87M | 1.46B | 549.88M | 459.23M | 235.67M | 250.02M | 332.33M | 540.86M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 625.31M | 938.08M | 1.25B | 0 | 0 | 0 | 0 |
| Intangible Assets | 443.13M | 403.14M | 556.66M | 1.19B | 1.28B | 0 | 0 | 0 | 872.37M |
| Total Liabilities | 5.19B | 4.28B | 7.44B | 9.49B | 12.07B | 11.06B | 10.67B | 9.46B | 10.39B |
| Total Debt | 4.96B | 4.06B | 7.11B | 9.01B | 11.37B | 10.41B | 10.22B | 8.98B | 128.3M |
| Net Debt | 4.78B | 3.24B | 5.65B | 8.46B | 10.91B | 10.18B | 9.97B | 8.64B | -412.56M |
| Long-Term Debt | 4.06B | 4.04B | 7.02B | 8.87B | 11.28B | 9.34B | 8.55B | 8.49B | 0 |
| Short-Term Borrowings | 0 | 0 | 5.6M | 51.3M | 4.2M | 929.58M | 1.51B | 361.73M | 128.3M |
| Capital Lease Obligations | 57.05M | 27.52M | 78.28M | 91.94M | 87.15M | 146.13M | 156.6M | 129.04M | 0 |
| Total Current Liabilities | 229.37M | 217.79M | 291.49M | 438.75M | 607.79M | 1.58B | 1.96B | 845.38M | 147.59M |
| Accounts Payable | 211.19M | 246.7M | 285.89M | 387.45M | 603.59M | 0 | 0 | 0 | 0 |
| Deferred Revenue | 18.18M | 13.47M | 0 | 0 | 0 | 27.73M | 37.96M | 29.45M | 19.29M |
| Other Liabilities | 840.81M | 0 | 45.72M | 89.01M | 96.41M | 0 | 0 | 0 | 10.25B |
| Total Equity | 3.84B▲ 0% | 4.56B▲ 18.9% | 7.03B▲ 54.1% | 7.34B▲ 4.5% | 8.45B▲ 15.0% | 8.59B▲ 1.8% | 7.63B▼ 11.2% | 4.83B▼ 36.7% | 4.61B▼ 4.7% |
| Equity Growth % | 17.89% | 18.92% | 54.09% | 4.49% | 15% | 1.76% | -11.18% | -36.68% | -4.66% |
| Shareholders Equity | 3.82B | 4.55B | 7.03B | 7.34B | 8.44B | 8.59B | 7.63B | 4.83B | 4.61B |
| Minority Interest | 14.57M | 13.83M | 107K | 5.33M | 5.48M | 1.57M | 2.27M | 1.05M | 1.05M |
| Common Stock | 364K | 371K | 518K | 541K | 597K | 597K | 599K | 600K | 0 |
| Additional Paid-in Capital | 4.33B | 4.44B | 7.01B | 7.46B | 8.56B | 8.54B | 8.56B | 8.58B | 0 |
| Retained Earnings | -485.93M | 162.77M | 83.01M | 0 | -87.69M | 116.28M | -971.81M | -3.66B | 0 |
| Preferred Stock | 49K | 202K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on Assets (ROA) | 3.75% | 11.38% | 3.21% | 2.76% | 3.51% | 4.49% | -2.93% | -14.79% | -1.36% |
| Return on Equity (ROE) | 8.18% | 24.22% | 6.47% | 6% | 8.31% | 10.59% | -6.86% | -38.66% | -4.21% |
| Debt / Assets | 54.94% | 45.96% | 49.13% | 53.53% | 55.43% | 52.98% | 55.84% | 62.8% | 0.86% |
| Debt / Equity | 1.29x | 0.89x | 1.01x | 1.23x | 1.35x | 1.21x | 1.34x | 1.86x | 0.03x |
| Net Debt / EBITDA | 7.75x | 4.62x | 6.23x | 7.66x | 7.95x | 7.54x | 14.30x | 10.28x | -14.69x |
| Book Value per Share | 10.94 | 12.45 | 16.41 | 13.84 | 14.31 | 14.35 | 12.75 | 8.05 | 7.67 |
Medical Properties Trust, Inc. (MPW) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 363.1M | 449.09M | 494.12M | 617.64M | 811.66M | 739.01M | 505.79M | 245.48M | 230.77M |
| Operating CF Growth % | 37.18% | 23.68% | 10.03% | 25% | 31.41% | -8.95% | -31.56% | -51.47% | -5.99% |
| Operating CF / Revenue % | 51.52% | 57.24% | 56.78% | 49.44% | 52.55% | 47.9% | 58.02% | 24.66% | 23.74% |
| Net Income | 291.24M | 1.02B | 376.4M | 432.27M | 656.94M | 903.82M | -556.09M | -2.41B | -277.05M |
| Depreciation & Amortization | 131.98M | 141.49M | 156.57M | 275.95M | 333.78M | 345.58M | 616.13M | 453.75M | 322.71M |
| Stock-Based Compensation | 9.95M | 16.5M | 32.19M | 47.15M | 52.11M | 49.42M | 33.25M | 32.98M | -10.26M |
| Other Non-Cash Items | -37.51M | -79M | -103.64M | -176.8M | -287.04M | -600.09M | 563.12M | 2.18B | 195.36M |
| Working Capital Changes | -25.12M | 23M | 53.13M | 17.22M | 13.12M | 29.59M | 16.72M | -15.6M | 0 |
| Cash from Investing | -2.36B | 564.18M | -4.88B | -2.95B | -3.86B | 396.06M | 517.56M | 1.32B | -264.74M |
| Acquisitions (Net) | -2.25B | -1.43B | -4.57B | -4.18B | -5.28B | -1.32B | -222.76M | -93.96M | 0 |
| Purchase of Investments | -94.97M | -138.44M | -293.16M | -36.18M | -289.24M | -207.39M | -294.17M | -156.08M | 0 |
| Sale of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 |
| Other Investing | -20.31M | 2.13B | 4.72B | 4.09B | 1.72B | 3.45B | 1.03B | 1.57B | -264.74M |
| Cash from Financing | 2.07B | -345.87M | 5.04B | 1.4B | 2.95B | -1.34B | -1.02B | -1.48B | 228.08M |
| Dividends Paid | -326.73M | -363.91M | -411.7M | -567.97M | -643.47M | -698.53M | -615.39M | -321.08M | 0 |
| Common Dividends | -326.73M | -363.91M | -411.7M | -567.97M | -643.47M | -698.53M | -615.39M | -321.08M | 0 |
| Debt Issuance (Net) | 1000K | -1000K | 1000K | 1000K | 1000K | -1000K | -1000K | 1000K | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -17.94M | 0 | 0 | 0 |
| Other Financing | -18.25M | -24.22M | -62.32M | -20.64M | -36.67M | -88.55M | 15.31M | -1.26B | 228.08M |
| Net Change in Cash | 88.23M▲ 0% | 650.18M▲ 636.9% | 645.57M▼ 0.7% | -911.62M▼ 241.2% | -94.49M▲ 89.6% | -220.34M▼ 133.2% | 14.41M▲ 106.5% | 79.22M▲ 449.6% | 208.82M▲ 163.6% |
| Exchange Rate Effect | 1000K | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K | -1000K | 0 |
| Cash at Beginning | 83.24M | 172.25M | 822.42M | 1.47B | 556.37M | 461.88M | 241.54M | 255.95M | 335.17M |
| Cash at End | 171.47M | 822.42M | 1.47B | 556.37M | 461.88M | 241.54M | 255.95M | 335.17M | 544M |
| Free Cash Flow | -1.88B▲ 0% | -981.91M▲ 47.9% | -4.36B▼ 344.5% | -3.67B▲ 16.0% | 746.11M▲ 120.3% | -801.35M▼ 207.4% | 505.79M▲ 163.1% | 245.48M▼ 51.5% | 230.77M▼ 6.0% |
| FCF Growth % | -744.57% | 47.87% | -344.51% | 15.97% | 120.34% | -207.4% | 163.12% | -51.47% | -5.99% |
| FCF / Revenue % | -267.29% | -125.16% | -501.54% | -293.6% | 48.3% | -51.94% | 58.02% | 24.66% | 23.74% |
Medical Properties Trust, Inc. (MPW) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FFO per Share | 1.24 | 1.2 | 3.16 | 1.24 | 1.33 | 1.68 | 2.08 | 0.1 | -3.26 | 0.11 |
| FFO Payout Ratio | 67.69% | 77.47% | 31.42% | 77.49% | 80.29% | 65.01% | 55.96% | 1031.65% | -16.41% | 0% |
| NOI Margin | 99.5% | 99.18% | 98.82% | 97.24% | 98.01% | 97.47% | 97.04% | 95.23% | 97.26% | 100% |
| Net Debt / EBITDA | 6.50x | 7.75x | 4.62x | 6.23x | 7.66x | 7.95x | 7.54x | 14.30x | 10.28x | -14.69x |
| Debt / Assets | 45.77% | 54.94% | 45.96% | 49.13% | 53.53% | 55.43% | 52.98% | 55.84% | 62.8% | 0.86% |
| Interest Coverage | 2.14x | 2.74x | 2.51x | 3.15x | - | 2.63x | 2.72x | 0.20x | 0.92x | - |
| Book Value / Share | 12.46 | 10.94 | 12.45 | 16.41 | 13.84 | 14.31 | 14.35 | 12.75 | 8.05 | 7.67 |
| Revenue Growth | 22.46% | 30.23% | 11.32% | 10.93% | 43.55% | 23.65% | -0.12% | -43.49% | 14.19% | -2.36% |
Medical Properties Trust, Inc. (MPW) SEC filings — annual & quarterly reports (10-K, 10-Q)
Feb 19, 2026·SEC
Jan 20, 2026·SEC
Oct 30, 2025·SEC
Medical Properties Trust, Inc. (MPW) stock FAQ — growth, dividends, profitability & financials explained
Medical Properties Trust, Inc. (MPW) reported $972.0M in revenue for fiscal year 2025. This represents a 8823% increase from $10.9M in 2004.
Medical Properties Trust, Inc. (MPW) saw revenue decline by 2.4% over the past year.
Medical Properties Trust, Inc. (MPW) reported a net loss of $198.7M for fiscal year 2025.
Medical Properties Trust, Inc. (MPW) has a return on equity (ROE) of -4.2%. Negative ROE indicates the company is unprofitable.
Medical Properties Trust, Inc. (MPW) generated Funds From Operations (FFO) of $67.6M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Medical Properties Trust, Inc. (MPW) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates